![](/images/Email.png)
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
SignalRx Pharmaceuticals, Inc.
US Patent
SignalRx Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 714nMAssay Description:Several TP Scaffold compounds were tested for inhibition activity against isoforms of PI3K (alpha, beta, gamma, and delta isoforms) and the bromodoma...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
SignalRx Pharmaceuticals, Inc.
US Patent
SignalRx Pharmaceuticals, Inc.
US Patent
Target InfoPDBMMDBNCI pathwayReactome pathwayKEGG
UniProtKB/SwissProt
B.MOADDrugBankantibodypediaGoogleScholar
UniProtKB/SwissProt
B.MOADDrugBankantibodypediaGoogleScholar
In DepthDetails
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
SignalRx Pharmaceuticals, Inc.
US Patent
SignalRx Pharmaceuticals, Inc.
US Patent
Affinity DataIC50: 714nMAssay Description:Inhibition of PI3K p110alpha (unknown origin)More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)